At Investor Conferences

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

News > All

Total search results: 1394 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire. 2020-01-14
Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona. 2020-01-09
Boehringer Ingelheim. (1/9/20). "Press Release: Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases". Ingelheim & Singapore. 2020-01-09
Avacta Group plc. (1/8/20). "Press Release: Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture". Cambridge & Seoul. 2020-01-08
Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. 2020-01-08
GlaxoSmithKline plc. (1/8/20). "Press Release: Deborah Waterhouse, CEO of ViiV Healthcare, to Join GSK Corporate Executive Team (CET)". London. 2020-01-08
Elpiscience Biopharma. (12/28/19). "Press Release: Elpiscience Completes Series B Financing of USD $100 Million". Shanghai. 2019-12-28
Astellas Pharma Inc.. (12/27/19). "Pressemitteilung: Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.". Tokyo & South San Francisco, CA. 2019-12-27
Epirium Bio, Inc.. (12/18/19). "Press Release: Epirium Raises $85 Million in Series A Financing to Advance Unique Scientific Platform Focused on Restoration of Tissue Bioenergetics and Function". San Francisco, CA. 2019-12-18
BC Platforms. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA. 2019-12-18
Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. 2019-12-17
Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe 2019-12-16
Numab Therapeutics AG. (12/12/19). "Press Release: Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian Form Partnership to Develop a Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil, Shengyang & Shanghai. 2019-12-12
Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). 2019-12-10
Stilla Technologies S.A.S.. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris. 2019-12-10
Jasper Therapeutics, Inc.. (12/6/19). "Press Release: Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants". Palo A 2019-12-06
Sartorius AG. (12/5/19). "Press Release: Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries". Göttingen. 2019-12-05
Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. 2019-12-04
Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier. 2019-12-02
Audentes Therapeutics, Inc.. (12/2/19). "Press Release: Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics". Tokyo & San Francisco, CA. 2019-12-02
Markes International Ltd.. (11/28/19). "Press Release: New Appointment Signals Asia Pacific Market Growth for Markes International". 2019-11-28
ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. 2019-11-28
Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. 2019-11-26
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. 2019-11-26
Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. 2019-11-25
Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. 2019-11-25
Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen. 2019-11-25
Alexandria Real Estate Equities, Inc.. (11/25/19). "Press Release: Alexandria Real Estate Equities, Inc. Partners With World-Class Life Science Consortium in Greater Boston". Pasadena, CA. 2019-11-25
Roche. (11/22/19). "Press Release: Roche Presents Pivotal Data Demonstrating Tecentriq in Combination with Avastin Improves Overall Survival in People with the Most Common Form of Liver Cancer". Basel. 2019-11-22
Werewolf Therapeutics, Inc.. (11/20/19). "Press Release: Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines". Cambridge, MA. 2019-11-20
Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt. 2019-11-20
Fujifilm Diosynth Biotechnologies U.S.A. Inc.. (11/14/19). "Press Release: Fujifilm Diosynth Biotechnologies Announces $55 Millionn USD Investment to Expand Gene Therapy Development Capabilities". College Station, TX. 2019-11-14
Fujifilm Corporation. (11/14/19). "Press Release: Fujifilm Announces Expansion of its Biopharmaceutical Contract Development and Manufacturing Business". Tokyo. 2019-11-14
Grifols S.A.. (11/13/19). "Press Release: Grifols and Shanghai RAAS Obtain Authorization for Their Strategic Alliance in China". Barcelona. 2019-11-13
Avacta Group plc. (11/13/19). "Press Release: LG Chem Life Sciences Expands Partnership with Avacta". 2019-11-13
Vaximm AG. (11/12/19). "Press Release: NEC and Vaximm Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines". Tokyo, Basel & Mannheim. 2019-11-12
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. 2019-11-11
BC Platforms. (11/7/19). "Press Release: BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine". Zürich & Boston, MA. 2019-11-07
AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development". 2019-11-06
Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. 2019-10-31
BeiGene, Ltd.. (10/31/19). "Press Release: BeiGene Announces Global Strategic Oncology Collaboration with Amgen". Cambridge, MA & Beijing. 2019-10-31
Phathom Pharmaceuticals, Inc.. (10/29/19). "Press Release: Phathom Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Buffalo Grove, IL. 2019-10-29
Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. 2019-10-29
BiomX Ltd.. (10/28/19). "Press Release: Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-28
AstraZeneca plc. (10/24/19). "Press Release: Year-to-Date and Q3 2019 Results". 2019-10-24
Phathom Pharmaceuticals, Inc.. (10/24/19). "Press Release: Phathom Pharmaceuticals Announces Pricing of Initial Public Offering". Buffalo Grove, IL. 2019-10-24
Pepticom. (10/24/19). "Press Release: Pepticom Raises $5 Million in Series A Funding. Jerusalem-based Startup Uses AI to Accelerate Drug Discovery". Jerusalem. 2019-10-24
BiomX Ltd.. (10/23/19). "Press Release: Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-23
Cision Ltd.. (10/22/19). "Press Release: Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion". Chicago. 2019-10-22
Qpex Biopharma, Inc.. (10/22/19). "Press Release: Qpex Biopharma and Brii Biosciences Enter into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-resistant Infections in China". San Diego, CA. 2019-10-22
Verseau Therapeutics, Inc.. (10/21/19). "Press Release: Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board". Bedford, MA. 2019-10-21
Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC. 2019-10-21
Sartorius AG. (10/21/19). "Press Release: Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses". Göttingen. 2019-10-21
Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA. 2019-10-21
Avacta Group plc. (10/18/19). "Press Release: Proposed Placing and Subscription to Raise up to £9 Million and Notice of General Meeting". 2019-10-18
Merck KGaA. (10/18/19). "Press Release: Merck Launches Seed Fund for Startups in China". Darmstadt. 2019-10-18
Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. 2019-10-16
GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. 2019-10-16
MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. 2019-10-14
BiomX Ltd.. (10/14/19). "Press Release: Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-14
Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. 2019-10-10
Insilico Medicine. (10/9/19). "Press Release: CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million". Hong Kong & Nanjing. 2019-10-09
Bluebee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk. 2019-10-09
Cyclica Inc.. (10/8/19). "Press Release: To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships". Toronto. 2019-10-08
Bayer AG. (10/8/19). "Press Release: Bayer and RIKEN Innovation Establish Partnership in Drug Discovery". Osaka & Tokyo. 2019-10-08
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. 2019-10-07
Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA. 2019-10-04
Agilent Technologies Inc.. (10/2/19). "Press Release: Agilent Receives Approval for First PD-L1 Companion Diagnostic in China". Santa Clara, CA. 2019-10-02
Numab Therapeutics AG. (10/1/19). "Press Release: Numab and Eisai Enter into a Global Research and Option Agreement to Discover and Develop Multi-specific Antibody Immunotherapies for Cancer". Tokyo & Zurich. 2019-10-01
Phathom Pharmaceuticals, Inc.. (9/27/19). "Press Release: Phathom Pharmaceuticals Announces Leadership Succession Plan and Strengthens Board of Directors with New Appointments". Buffalo Grove, IL. 2019-09-27
Forma Therapeutics, Inc.. (9/24/19). "Press Release: Forma Therapeutics Announces New Executive Leadership to Execute Next Phase of Growth for Company". Watertown, MA. 2019-09-24
Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg. 2019-09-24
H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan". 2019-09-20
Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. 2019-09-20
Agilent Technologies Inc.. (9/19/19). "Press Release: Agilent Presents Thought Leader Award to Professor Hualiang Jiang". Santa Clara, CA. 2019-09-19
BenevolentAI Ltd.. (9/17/19). "Press Release: BenevolentAI Announces $90 Million Investment from Temasek". London. 2019-09-17
Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris. 2019-09-12
Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA. 2019-09-11
Atomwise, Inc.. (9/11/19). "Press Release: Atomwise Announces Largest China-US Collaboration for AI Drug Discovery". San Francisco, CA. 2019-09-11
Genenta Science S.r.l.. (9/11/19). "Press Release: Genenta Science Announces 13.2 Million in a New Round of Financing, Hits a Total above 30 Million since Inception. Two Clinical Trials Ongoing.". Milano & New York, NY. 2019-09-11
Insilico Medicine. (9/10/19). "Press Release: Insilico Medicine Secures $37m in Series B Funding Led by Qiming Venture Partners". Hong Kong. 2019-09-10
Amra Medical AB. (9/10/19). "Press Release: Amra Announces Strategic Partnership with Japanese Leading Imaging CRO, Micron, Inc., to Support Clinical Trials in Japan". Linköping. 2019-09-10
Evonik Industries AG. (9/5/19). "Press Release: Evonik Invests in Chinese 3D-printing Start-up Making Medical Implants". Essen & Shanghai. 2019-09-05
AB Sciex (d/b/a Sciex). (9/5/19). "Press Release: Sciex Launches Partner Portal to Support Customer Needs Worldwide and Extend Network". Framingham, MA. 2019-09-05
Boehringer Ingelheim. (9/4/19). "Press Release: Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound". Ingelheim & Mumbai. 2019-09-04
Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen. 2019-08-28
Agilent Technologies Inc.. (8/28/19). "Press Release: Agilent Presents Thought Leader Award to Professor Hyun Joo An". Santa Clara, CA. 2019-08-28
HiFiBio Therapeutics. (8/28/19). "Press Release: HiFiBio Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders". Cambridge, MA, Shanghai & Paris. 2019-08-28
Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire. 2019-08-27
Atonarp Inc.. (8/26/19). "Press Release: Atonarp Inc. Announces $33 Million Series C Funding Round Completion". Tokyo. 2019-08-26
GlaxoSmithKline plc. (8/23/19). "Press Release: GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple MMyeloma". London. 2019-08-23
AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease". 2019-08-22
Finch Therapeutics Group, Inc.. (8/22/19). "Press Release: Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas". Somerville, MA. 2019-08-22
Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. 2019-08-21
Inex Innovate. (8/21/19). "Press Release: Inex and Nova Satra Announce Merger to Become Inex Innovate, Asia’s First Femtech Innovations Group". Singapore. 2019-08-21
GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London. 2019-08-21
Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund. 2019-08-20
Genomenon, Inc.. (8/20/19). "Press Release: Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market". Ann Arbor, MI. 2019-08-20
H. Lundbeck A/S. (8/14/19). "Press Release: Lundbeck Appoints New EVP, People & Communication". Valby. 2019-08-14
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

» top